Lupin makes debut in US ophthalmology space with exclusivity for gatifloxacin
This article was originally published in Scrip
Executive Summary
Lupin has launched gatifloxacin ophthalmic solution 0.5%, a generic version of Allergan's Zymaxid ophthalmic solution 0.5%, on the US market – its first such launch in the ophthalmology segment there.